AI assistant
Entera Bio Ltd. — Major Shareholding Notification 2020
Feb 27, 2020
35604_mrq_2020-02-27_68ae0a29-5b93-41d0-85ac-61f88298518b.zip
Major Shareholding Notification
Open in viewerOpens in your device viewer
SC 13G/A 1 dp122224_sc13ga1.htm FORM SC 13G/A
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Field: Rule-Page
Field: /Rule-Page
SCHEDULE 13G
(Rule 13d-102)
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
Amendment No.1
Field: Rule-Page
Field: /Rule-Page
ENTERA BIO LTD.
(Name of Issuer)
Ordinary Shares, nominal value of NIS 0.0000769 per share
(Title of Class of Securities)
M40527109
(CUSIP Number)
December 31, 2019
(Date of Event Which Requires Filing of this Statement)
Field: Rule-Page
Field: /Rule-Page
Check the appropriate box to designate the rule pursuant to which this schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
- The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Field: Page; Sequence: 1
Field: /Page
CUSIP No. M40527109 13G Page 2 of 6 Pages
| 1 | NAME OF REPORTING PERSON Phillip Schwartz |
|---|---|
| 2 | CHECK THE APPROPRIATE |
| BOX IF A MEMBER OF A GROUP* (a) ☐ (b) ☐ | |
| 3 | SEC USE ONLY |
| 4 | CITIZENSHIP OR PLACE |
| OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | SOLE VOTING POWER 780,504 Shares |
|---|---|
| 6 | SHARED VOTING POWER 0 |
| 7 | SOLE DISPOSITIVE POWER 780,504 Shares |
| 8 | SHARED DISPOSITIVE POWER 0 |
| 9 | AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON 780,504 Shares |
| --- | --- |
| 10 | CHECK IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
| 11 | PERCENT OF CLASS REPRESENTED
BY AMOUNT IN ROW (9) 4.32% |
| 12 | TYPE OF REPORTING PERSON IN |
Field: Page; Sequence: 2
Field: /Page
CUSIP No. M40527109 13G Page 3 of 6 Pages
Item 1(a). Name of Issuer
The name of the issuer to which this filing on Schedule 13G relates is Entera Bio Ltd. (the “Company”).
Item 1(b). Address of Issuer’s Principal Executive Offices
The principal executive offices of the Company are located at Kiryat Hadassah Minrav Building - Fifth Floor, Jerusalem 9112002 Israel.
Item 2(a). Name of Person Filing
This statement is being filed on behalf of Phillip Schwartz, a United States citizen (the “Reporting Person”).
Item 2(b). Address of Principal Business Office or, if none, Residence
The principal business address of the Reporting Person is Kiryat Hadassah Minrav Building - Fifth Floor, Jerusalem 9112002 Israel.
Item 2(c). Citizenship
The Reporting Person is a citizen of the United States.
Item 2(d). Title of Class of Securities
The class of equity securities of the Company to which this filing on Schedule 13G relates is Ordinary Shares, nominal value of NIS 0.0000769 per share (the “Ordinary Shares”).
Item 2(e). CUSIP Number
The CUSIP number of the Company’s Ordinary Shares is M40527109.
ITEM 3. If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable.
Field: Page; Sequence: 3
Field: /Page
| (a) | [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). |
|---|---|
| (b) | [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). |
| (d) | [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | [ ] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). |
| (f) | [ ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F). |
| (g) | [ ] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). |
| (h) | [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). |
| (i) | [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3). |
| (j) | [ ] A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J). |
| (k) | [ ] Group, in accordance with §240.13d-1(b)(1)(ii)(K). |
ITEM 4. Ownership
Item 4(a). Amount beneficially owned
As of the close of business on December 31, 2019, the Reporting Person beneficially owned 780,504 Ordinary Shares, representing 4.32% of the Company’s outstanding Ordinary Shares consists of (i) 579,410 Ordinary Shares and (ii) 201,094 Ordinary Shares underlying options to acquire Ordinary Shares, exercisable within 60 days of December 31, 2019. The percentage of the Company’s outstanding Ordinary Shares owned by the Reporting Person is based on 18,065,778 Ordinary Shares outstanding as of December 31, 2019, assuming the exercise of options, exercisable within 60 days of December 31, 2019, by the Reporting Person.
Item 4(b). Percent of Class
See Item 4(a) hereof.
Item 4(c). Number of shares as to which such person has :
(i) sole power to vote or to direct the vote: 780,504
(ii) shared power to vote or to direct the vote: 0
(iii) sole power to dispose or to direct the disposition of: 780,504
(iv) shared power to dispose or to direct the disposition of: 0
ITEM 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the Reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following: [X]
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Field: Page; Sequence: 4
Field: /Page
ITEM 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person :
Not applicable.
ITEM 8. Identification and Classification of Members of the Group
Not applicable.
ITEM 9. Notice of Dissolution of Group
Not applicable.
ITEM 10. Certification
Not applicable.
Field: Page; Sequence: 5
Field: /Page
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this Statement is true, complete and correct.
Dated: February 27, 2020
| Phillip Schwartz | |
|---|---|
| By: | /s/ Phillip Schwartz |
| Name: | Phillip Schwartz |
| Title: | Executive Vice President |
Field: Page; Sequence: 6; Options: Last
Field: /Page